Joel G. DeKoven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joel G. DeKoven has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
Melanie D. Pratt
Division of Dermatology University of Ottawa Ottawa Ontario Canada
6 shared publications- Denis Sasseville
McGill University
5 shared publications - Erin M. Warshaw
Department of Dermatology, Park Nicollet/Health Partners Health Services, Minneapolis, Minnesota, USA
5 shared publications Howard I. Maibach
Department of Dermatology University of California San Francisco San Francisco California USA
5 shared publicationsJames S. Taylor
Department of Dermatology Cleveland Clinic Cleveland Ohio USA
5 shared publications- Jonathan Ian Silverberg
Department of Dermatology, The George Washington University School of Medicine and Health Sciences , Washington, DC
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 14
Systemic allergic contact dermatitis to nickel presenting predominantly as severe hand dermatitis, successfully controlled with upadacitinib: A case report
Systemic allergic contact dermatitis to nickel is a challenging condition often presenting as severe hand dermatitis. This case report details the clinical course of a 33-year-old male truck driver with severe hand dermatitis secondary to systemic allergic contact dermatitis to nickel. Despite significant improvement with avoidance, the patient experienced recurrent flares due to ongoing accidental nickel exposure. Upadacitinib provided an effective salvage strategy. The case underlines challenges of managing systemic allergic contact dermatitis.
- 1 January 2026
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 14
Open AccessSystemic allergic contact dermatitis to nickel presenting predominantly as severe hand dermatitis, successfully controlled with upadacitinib: A case report
Systemic allergic contact dermatitis to nickel is a challenging condition often presenting as severe hand dermatitis. This case report details the clinical course of a 33-year-old male truck driver with severe hand dermatitis secondary to systemic allergic contact dermatitis to nickel. Despite significant improvement with avoidance, the patient experienced recurrent flares due to ongoing accidental nickel exposure. Upadacitinib provided an effective salvage strategy. The case underlines challenges of managing systemic allergic contact dermatitis.
- Open Access
- 27 January 2025
- Published by Wiley in Contact Dermatitis
- Vol. 92 (5) , 401-402
If Left to Your Own Devices, Consider Colophony
- 27 January 2025
- Published by Wiley in Contact Dermatitis
- Vol. 92 (5) , 401-402
Open AccessIf Left to Your Own Devices, Consider Colophony
- Open Access
- 21 August 2024
- Published by Wiley in Contact Dermatitis
- Vol. 91 (6) , 465-473
Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009–2020
Background: Photoallergic contact dermatitis (PACD) is a delayed hypersensitivity reaction to allergens only in the presence of ultraviolet radiation in sunlight. Photopatch testing (PhotoPT) is necessary to confirm the diagnosis of PACD. There are few published studies of PhotoPT in North America.Objective: To summarise the results of patients photopatch tested by members of the North American Contact Dermatitis Group (NACDG), 2009–2020.Methods: Retrospective analysis of patient characteristics and PhotoPT results to 32 allergens on the NACDG Photopatch Test Series.Results: Most of the 454 tested patients were female (70.3%), 21–60 years old (66.7%) and White (66.7%). There were a total of 119 positive photopatch tests. Sunscreen agents comprised 88.2% of those, with benzophenones responsible for over half of them. Final diagnoses included PACD in 17.2%, allergic contact dermatitis (ACD) in 44.5%, polymorphous light eruption (PMLE) in 18.9% and chronic actinic dermatitis (CAD) in 9.0% of patients.Conclusions: In 454 patients with suspected photosensitivity referred for photopatch testing in North America, approximately one‐fifth had PACD. Sunscreen agents, especially benzophenones, were the most common photoallergens. Other common diagnoses included ACD, PMLE and CAD. Photopatch testing is an important tool for differentiating these conditions.
- 21 August 2024
- Published by Wiley in Contact Dermatitis
- Vol. 91 (6) , 465-473
Open AccessPhotopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009–2020
Background: Photoallergic contact dermatitis (PACD) is a delayed hypersensitivity reaction to allergens only in the presence of ultraviolet radiation in sunlight. Photopatch testing (PhotoPT) is necessary to confirm the diagnosis of PACD. There are few published studies of PhotoPT in North America.Objective: To summarise the results of patients photopatch tested by members of the North American Contact Dermatitis Group (NACDG), 2009–2020.Methods: Retrospective analysis of patient characteristics and PhotoPT results to 32 allergens on the NACDG Photopatch Test Series.Results: Most of the 454 tested patients were female (70.3%), 21–60 years old (66.7%) and White (66.7%). There were a total of 119 positive photopatch tests. Sunscreen agents comprised 88.2% of those, with benzophenones responsible for over half of them. Final diagnoses included PACD in 17.2%, allergic contact dermatitis (ACD) in 44.5%, polymorphous light eruption (PMLE) in 18.9% and chronic actinic dermatitis (CAD) in 9.0% of patients.Conclusions: In 454 patients with suspected photosensitivity referred for photopatch testing in North America, approximately one‐fifth had PACD. Sunscreen agents, especially benzophenones, were the most common photoallergens. Other common diagnoses included ACD, PMLE and CAD. Photopatch testing is an important tool for differentiating these conditions.
- Open Access
- 17 October 2023
- Published by Wiley in Contact Dermatitis
- Vol. 90 (2) , 182-184
Usefulness of a ‘workplace prescription’ as a resource for return‐to‐work
- 17 October 2023
- Published by Wiley in Contact Dermatitis
- Vol. 90 (2) , 182-184
Open AccessUsefulness of a ‘workplace prescription’ as a resource for return‐to‐work
- 29 July 2023
- Published by Springer Nature in Current Dermatology Reports
- Vol. 12 (3) , 154
Correction to: Occupational Contact Dermatitis: An Individualized Approach to the Worker with Dermatitis
- 29 July 2023
- Published by Springer Nature in Current Dermatology Reports
- Vol. 12 (3) , 154
Correction to: Occupational Contact Dermatitis: An Individualized Approach to the Worker with Dermatitis
- 20 December 2022
- Published by Wiley in Contact Dermatitis
- Vol. 88 (4) , 300-314
Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001–2018
Background: An updated understanding of allergic contact cheilitis is needed. Objectives: To characterize clinical characteristics and allergen relevance in patients with cheilitis referred for patch testing.Methods: Retrospective analysis of 43 772 patients patch tested with the North American Contact Dermatitis Group (NACDG) screening series from 2001 to 2018. Results: Overall, 2094 patients (4.8%) had lips as one of three sites of dermatitis, 1583 (3.6%) had lips as the primary site and 1167 (2.7%) had lips as the sole site of dermatitis. Prevalences of cheilitis at any, primary, and sole sites significantly increased throughout the study cycle from 2001-2002 (2.7%, 2.2% and 1.7%) to 2017-2018 (7.8%, 5.2% and 3.7%). Approximately 60% of patients with any, a primary, or a sole site of cheilitis had one or more positive allergic patch-test reactions compared to 65% of those without cheilitis.Conclusion: Patients with cheilitis who were referred for patch testing had high rates of positive and relevant allergens. More than one in four patients with any, primary, or sole cheilitis had a positive reaction to non-NACDG screening allergens (28.0%, 26.8%, 31.1% vs. 21.6%) compared to patients without cheilitis, emphasizing the need for expanded patch test series in cheilitis.
- 20 December 2022
- Published by Wiley in Contact Dermatitis
- Vol. 88 (4) , 300-314
Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001–2018
Background: An updated understanding of allergic contact cheilitis is needed. Objectives: To characterize clinical characteristics and allergen relevance in patients with cheilitis referred for patch testing.Methods: Retrospective analysis of 43 772 patients patch tested with the North American Contact Dermatitis Group (NACDG) screening series from 2001 to 2018. Results: Overall, 2094 patients (4.8%) had lips as one of three sites of dermatitis, 1583 (3.6%) had lips as the primary site and 1167 (2.7%) had lips as the sole site of dermatitis. Prevalences of cheilitis at any, primary, and sole sites significantly increased throughout the study cycle from 2001-2002 (2.7%, 2.2% and 1.7%) to 2017-2018 (7.8%, 5.2% and 3.7%). Approximately 60% of patients with any, a primary, or a sole site of cheilitis had one or more positive allergic patch-test reactions compared to 65% of those without cheilitis.Conclusion: Patients with cheilitis who were referred for patch testing had high rates of positive and relevant allergens. More than one in four patients with any, primary, or sole cheilitis had a positive reaction to non-NACDG screening allergens (28.0%, 26.8%, 31.1% vs. 21.6%) compared to patients without cheilitis, emphasizing the need for expanded patch test series in cheilitis.
- 14 October 2022
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 87 (5) , A12-A62
Table of Contents
- 14 October 2022
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 87 (5) , A12-A62
Table of Contents
- 23 July 2022
- Published by Wiley in Contact Dermatitis
- Vol. 87 (5) , 420-429
Patch testing with cobalt in children and adolescents: North American contact dermatitis group experience, 2001–2018
Background: Allergic contact dermatitis (ACD) to cobalt is more common in children and adolescents than adults. However, detailed information on sites and sources of cobalt ACD is limited.Objectives: To assess trends in positive and clinically relevant patch test reactions to cobalt in children and associated patient characteristics, common sources and body sites affected.Methods: A retrospective analysis of children (p = 0.0160 andp = 0.0008) and ears (p = 0.0005 andp < 0.0001). Affected body site(s) varied by cobalt source among patients with currently relevant reactions, especially for less common sources. The most commonly identified sources of cobalt included jewellery, belts and clothing.Conclusions: Positive patch test reactions to cobalt were common in children. The most common body site was scattered generalized and the sources of cobalt varied by body site.
- 23 July 2022
- Published by Wiley in Contact Dermatitis
- Vol. 87 (5) , 420-429
Patch testing with cobalt in children and adolescents: North American contact dermatitis group experience, 2001–2018
Background: Allergic contact dermatitis (ACD) to cobalt is more common in children and adolescents than adults. However, detailed information on sites and sources of cobalt ACD is limited.Objectives: To assess trends in positive and clinically relevant patch test reactions to cobalt in children and associated patient characteristics, common sources and body sites affected.Methods: A retrospective analysis of children (p = 0.0160 andp = 0.0008) and ears (p = 0.0005 andp < 0.0001). Affected body site(s) varied by cobalt source among patients with currently relevant reactions, especially for less common sources. The most commonly identified sources of cobalt included jewellery, belts and clothing.Conclusions: Positive patch test reactions to cobalt were common in children. The most common body site was scattered generalized and the sources of cobalt varied by body site.
- 27 January 2022
- Published by Wiley in Contact Dermatitis
- Vol. 86 (5) , 436-437
A case of contact urticaria to sorbitan sesquioleate in topical corticosteroids
- 27 January 2022
- Published by Wiley in Contact Dermatitis
- Vol. 86 (5) , 436-437
A case of contact urticaria to sorbitan sesquioleate in topical corticosteroids
- 1 December 2021
- Published by SAGE Publications in Dermatitis®
- Vol. 32 (6) , E127-E129
Patch Test Reactions Associated with Nontopical Medications: A Retrospective Analysis of North American Contact Dermatitis Group Data, 2001–2018
- 1 December 2021
- Published by SAGE Publications in Dermatitis®
- Vol. 32 (6) , E127-E129
Patch Test Reactions Associated with Nontopical Medications: A Retrospective Analysis of North American Contact Dermatitis Group Data, 2001–2018